|
|
| | EBOV-IN-8 Basic information |
| Product Name: | EBOV-IN-8 | | Synonyms: | EBOV-IN-8;Thieno[3,4-c][2,1]benzothiazepine, 5,10-dihydro-5-methyl-10-[2-(1-piperidinyl)ethoxy]-, 4,4-dioxide, (2Z)-2-butenedioate (1:1) | | CAS: | 286854-12-4 | | MF: | C19H24N2O3S2.C4H4O4 | | MW: | 508.61 | | EINECS: | | | Product Categories: | | | Mol File: | 286854-12-4.mol |  |
| | EBOV-IN-8 Chemical Properties |
| | EBOV-IN-8 Usage And Synthesis |
| Uses | EBOV-IN-8 (Compound 30) inhibits Ebola pseudotyped virus (pEBOV) infection with an IC50 of 62.1% at 10 μM[1]. | | IC 50 | EBOV | | References | [1] Lasala F, et al. Identification of potential inhibitors of protein-protein interaction useful to fight against Ebola and other highly pathogenic viruses. Antiviral Res. 2021 Feb;186:105011. DOI:10.1016/j.antiviral.2021.105011 |
| | EBOV-IN-8 Preparation Products And Raw materials |
|